SB High-Dose Augmentin May Aid Compliance With Sinusitis Guideline
Executive Summary
SmithKline Beecham's pending high-dose formulation of the antibiotic Augmentin may position the company to benefit from the antimicrobial treatment guidelines recently issued by the Sinus & Allergy Health Partnership.
You may also be interested in...
GSK Augmentin ES Needs "Boundary" On Resistant Strains Covered, FDA Cmte
GlaxoSmithKline should indicate an upper "boundary" of penicillin resistance that its antibiotic Augmentin ES is expected to effectively treat, FDA's Anti-Infective Drugs Advisory Committee suggested Jan. 30.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011